메뉴 건너뛰기




Volumn 21, Issue 4, 2013, Pages 993-1005

Structure-activity relationship of benzodiazepine derivatives as LXXLL peptide mimetics that inhibit the interaction of vitamin D receptor with coactivators

Author keywords

Antagonist; Cofactor; LXXLL; Non peptide; Nuclear receptor; Protein interaction inhibitor; Structure activity relationship; Vitamin D

Indexed keywords

1,2,4,5 TETRAHYDRO 2 (2 METHYLPROPYL) 3H 1,4 BENZODIAZEPIN 3 ONE; 1,2,4,5 TETRAHYDRO 4 (3 METHYLBUTYL) 2 (2 METHYLPROPYL) 3H 1,4 BENZODIAZEPIN 3 ONE; 1,2,4,5 TETRAHYDRO 4 (3 METHYLBUTYL) 2,7 DI(2 METHYLPROPYL) 3H 1,4 BENZODIAZEPIN 3 ONE; 1,2,4,5 TETRAHYDRO 4 (3 METHYLBUTYL) 7 (2 METHYLPROPYL 1 ENYL) 2 (2 METHYLPROPYL) 3H 1,4 BENZODIAZEPIN 3 ONE; 1,2,4,5 TETRAHYDRO 7 (3 HYDROXYPROP 1 ENYL) 4 (3 METHYLBUTYL) 2 (2 METHYLPROPYL) 3H 1,4 BENZODIAZEPIN 3 ONE; 1,2,4,5 TETRAHYDRO 7 (3 HYDROXYPROPYL) 4 (3 METHYLBUTYL) 2 (2 METHYLPROPYL) 3H 1,4 BENZODIAZEPIN 3 ONE; 1,2,4,5 TETRAHYDRO 7 (4 HYDROXYBUT 1 ENYL) 4 (3 METHYLBUTYL) 2 (2 METHYLPROPYL) 3H 1,4 BENZODIAZEPIN 3 ONE; 1,2,4,5 TETRAHYDRO 7 (4 HYDROXYBUTYL) 4 (3 METHYLBUTYL) 2 (2 METHYLPROPYL) 3H 1,4 BENZODIAZEPIN 3 ONE; 1,2,4,5 TETRAHYDRO 7 [4 (TERT BUTYLDIMETHYLSILYLOXY)BUTYL] 4 (3 METHYLBUTYL) 2 (2 METHYLPROPYL) 3H 1,4 BENZODIAZEPIN 3 ONE; 1,2,4,5 TETRAHYDRO 7 IODO 4 (3 METHYLBUTYL) 2 (2 METHYLPROPYL) 3H 1,4 BENZODIAZEPIN 3 ONE; 3 (TERT BUTYLDIMETHYLSILYLOXY)PROP 1 ENYLBORONIC ACID; 4 (TERT BUTYLDIMETHYLSILYLOXY)BUT 1 ENYLBORONIC ACID; 7 (BUT 1 ENYL) 1,2,4,5 TETRAHYDRO 4 (3 METHYLBUTYL) 2 (2 METHYLPROPYL) 3H 1,4 BENZODIAZEPIN 3 ONE; 8 AMINO 1,2,4,5 TETRAHYDRO 4 (3 METHYLBUTYL) 2 (2 METHYLPROPYL) 7 PENTYL 3H 1,4 BENZODIAZEPIN 3 ONE; 8 AMINO 4 (3 METHYLBUTYL) 2 (2 METHYLPROPYL) 1,2,4,5 TETRAHYDRO 7 (PENT 1 ENYL) 3H 1,4 BENZODIAZEPIN 3 ONE; 8 AMINO 4 (3 METHYLBUTYL) 2 (2 METHYLPROPYL) 1,2,4,5 TETRAHYDROHYDRO 7 PENTYL 3H 1,4 BENZODIAZEPIN 3 ONE; 8 AMINO 7 BUTYL 4 (3 METHYLBUTYL) 2 (2 METHYLPROPYL) 1,2,4,5 TETRAHYDROHYDRO 3H 1,4 BENZODIAZEPIN 3 ONE; 8 BIS(TERT BUTOXYCARBONYL)AMINO 1,2,4,5 TETRAHYDRO 2 (2 METHYLPROPYL) 3H 1,4 BENZODIAZEPIN 3 ONE; 8 BIS(TERT BUTOXYCARBONYL)AMINO 1,2,4,5 TETRAHYDRO 4 (3 METHYLBUT 2 ENYL) 2 (2 METHYLPROPYL) 3H 1,4 BENZODIAZEPIN 3 ONE; BENZODIAZEPINE DERIVATIVE; ETHYL 3 [2 (BENZYLOXY)ETHOXY] 4 IODOBENZOATE; ETHYL 3 HYDROXY 4 IODOBENZOATE; ETHYL 4 [8 AMINO 1,2,4,5 TETRAHYDRO 2 (2 METHYLPROPYL) 4 (3 METHYLBUTYL) 3 OXO 3H 1,4 BENZODIAZEPIN 7 YL] 3 (2 HYDROXYETHOXY)BENZOATE; ETHYL 4 [8 AMINO 1,2,4,5 TETRAHYDRO 2 (2 METHYLPROPYL) 4 (3 METHYLBUTYL) 3 OXO 3H 1,4 BENZODIAZEPIN 7 YL] 3 [2 (BENZYLOXY)ETHOXY]BENZOATE; ETHYL 4 [8 AMINO 1,2,4,5 TETRAHYDRO 2 (2 METHYLPROPYL) 4 (3 METHYLBUTYL) 3 OXO 3H 1,4 BENZODIAZEPIN 7 YL]BENZOATE; LXXLL PEPTIDE; NUCLEAR RECEPTOR COACTIVATOR; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN D RECEPTOR;

EID: 84873320439     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2012.11.042     Document Type: Article
Times cited : (26)

References (20)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.